This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lenhard, J. M. Articles by Winegar, D. A. Search for Related Content PubMed PubMed Citation Articles by Lenhard, J. M. Articles by Winegar, D. A. Related Collections Lipids Animal models of human disease Risk Factors Energy metabolism Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2625.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis

James M. Lenhard; Dallas K. Croom; James E. Weiel; Deborah A. Winegar

From the Department of Metabolic Diseases, GlaxoWellcome Inc, Research Triangle Park, NC.

Correspondence to James M. Lenhard, PhD, GlaxoWellcome Inc, 5 Moore Dr, Research Triangle Park, NC 27709. E-mail jml29514{at}glaxowellcome.com

Abstract—Hyperlipidemia may complicate the use of HIV protease inhibitors (PIs) in AIDS therapy. To determine the cause of hyperlipidemia, the effect of PIs on lipid metabolism was examined with HepG2 liver cells and AKR/J mice. In HepG2 cells, the PIs ABT-378, nelfinavir, ritonavir, and saquinavir stimulated triglyceride synthesis; ritonavir increased cholesterol synthesis; and amprenavir and indinavir had no effect. Moreover, nelfinavir increased mRNA expression of diacylglycerol acyltransferase and fatty acid synthase. The retinoid X receptor agonist LG100268, but not the antagonist LG100754, further increased PI-stimulated triglyceride synthesis and mRNA expression of fatty acid synthase in vitro. In fed mice, nelfinavir or ritonavir did not affect serum glucose and cholesterol, whereas triglyceride and fatty acids increased 57% to 108%. In fasted mice, ritonavir increased serum glucose by 29%, cholesterol by 40%, and triglyceride by 99%, whereas nelfinavir had no effect, suggesting these PIs have different effects on metabolism. Consistent with the in vitro results, nelfinavir and ritonavir increased triglyceride 2- to 3-fold in fasted mice injected with Triton WR-1339, an inhibitor of triglyceride clearance. We propose that PI-associated hyperlipidemia is due to increased hepatic triglyceride synthesis and suggest that retinoids or meal restriction influences the effects of select PIs on lipid metabolism.

Key Words: HIV • hypertriglyceridemia • liver • protease inhibitor • retinoid

This article has been cited by other articles:

				T. T. Brown Approach to the Human Immunodeficiency Virus-Infected Patient with Lipodystrophy J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2937 - 2945. [Abstract] [Full Text] [PDF]

				C. G. Morse and J. A. Kovacs Metabolic and skeletal complications of HIV infection: the price of success. JAMA, August 16, 2006; 296(7): 844 - 854. [Abstract] [Full Text] [PDF]

				A. A. Spector HIV Protease Inhibitors and Hyperlipidemia: A Fatty Acid Connection Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 7 - 9. [Full Text] [PDF]

				M. A.M. den Boer, J. F.P. Berbee, P. Reiss, M. van der Valk, P. J. Voshol, F. Kuipers, L. M. Havekes, P. C.N. Rensen, and J. A. Romijn Ritonavir Impairs Lipoprotein Lipase-Mediated Lipolysis and Decreases Uptake of Fatty Acids in Adipose Tissue Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 124 - 129. [Abstract] [Full Text] [PDF]

				R. A. Parker, O. P. Flint, R. Mulvey, C. Elosua, F. Wang, W. Fenderson, S. Wang, W.-P. Yang, and M. A. Noor Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors Mol. Pharmacol., June 1, 2005; 67(6): 1909 - 1919. [Abstract] [Full Text] [PDF]

				S. Grinspoon and A. Carr Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults N. Engl. J. Med., January 6, 2005; 352(1): 48 - 62. [Full Text] [PDF]

				M Schutt, J Zhou, M Meier, and H H Klein Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells J. Endocrinol., December 1, 2004; 183(3): 445 - 454. [Abstract] [Full Text] [PDF]

				S. Bellosta, R. Paoletti, and A. Corsini Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions Circulation, June 15, 2004; 109(23_suppl_1): III-50 - III-57. [Abstract] [Full Text]

				A. Xu, S. Yin, L. Wong, K. Weng Chan, and K. S. L. Lam Adiponectin Ameliorates Dyslipidemia Induced by the Human Immunodeficiency Virus Protease Inhibitor Ritonavir in Mice Endocrinology, February 1, 2004; 145(2): 487 - 494. [Abstract] [Full Text] [PDF]

				H. Tran, S. Robinson, I. Mikhailenko, and D. K. Strickland Modulation of the LDL receptor and LRP levels by HIV protease inhibitors J. Lipid Res., October 1, 2003; 44(10): 1859 - 1869. [Abstract] [Full Text] [PDF]

				J. M. Petit, M. Duong, E. Florentin, L. Duvillard, P. Chavanet, J. M. Brun, H. Portier, P. Gambert, and B. Verges Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study J. Lipid Res., September 1, 2003; 44(9): 1692 - 1697. [Abstract] [Full Text] [PDF]

				N. Leung, R. A. Hegele, and G. F. Lewis Rapid Development of Massive Tendon Xanthomas following Highly Active Antiretroviral Therapy Ann Intern Med, October 1, 2002; 137(7): 624 - 624. [Full Text] [PDF]

				R. G. Jain and J. M. Lenhard Select HIV Protease Inhibitors Alter Bone and Fat Metabolism ex Vivo J. Biol. Chem., May 24, 2002; 277(22): 19247 - 19250. [Abstract] [Full Text] [PDF]

				J. H. Stein, M. A. Klein, J. L. Bellehumeur, P. E. McBride, D. A. Wiebe, J. D. Otvos, and J. M. Sosman Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction Circulation, July 17, 2001; 104(3): 257 - 262. [Abstract] [Full Text] [PDF]